“Remestemcel-L has been granted Fast Track Designation and BLA Priority Review from the FDA”. Is it a new news, or we hd already known it?
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.8¢ |
Change
0.018(1.82%) |
Mkt cap ! $1.118B | |||
| Open | High | Low | Value | Volume |
| 97.0¢ | 99.5¢ | 97.0¢ | $1.199M | 1.223M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 138684 | 97.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 98.0¢ | 35652 | 20 |
View Market Depth
| Last trade - 12.08pm 22/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |